Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Other Infectious Diseases 1 Neoplasms 1 Febrile Neutropenia 1

Interventions

Meropenem 5 Ceftazidime 4 Levofloxacin 3 Filgrastim 3 Ciprofloxacin 3 Cefepime 3 Amikacin 3 pegfilgrastim 2 Vancomycin 2 Interleukin 1 Receptor Antagonist Protein 2 Anti-Bacterial Agents 2 Amoxicillin-Potassium Clavulanate Combination 2 pegylated granulocyte colony-stimulating factor 1 Therapeutics 1 Teicoplanin 1 Tazobactam 1 TKN732 1 Surveys and Questionnaires 1 Positron Emission Tomography Computed Tomography 1 Piperacillin 1 Ofloxacin 1 NF protocol 1 Micafungin 1 Metronidazole 1 Magnetic Resonance Myelography 1 Lead 1 Injections 1 Granulocyte Colony-Stimulating Factor 1 Cloxacillin 1 Cilastatin, Imipenem Drug Combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Febrile Neutropenia × Tazobactam × Clear all

NCT04948463 2026-03-20

ELSA-FN

Murdoch Childrens Research Institute

Phase 4 Completed

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡